16th Medicine Forum

• Life Sciences
• Reports

Assessing the economic case for Alzheimer’s disease policy prioritisation

The analysis has highlighted specific areas where more urgent action is needed, specifically: Accelerating diagnosing patients at scale; Supporting expansion...

• Market Research in Life Sciences
• CRA Insights

Cash-pay is no longer a side channel

Direct-to-consumer (DTC) and cash-pay models are not simply creating another access route, they are beginning to influence payer strategy, employer benefit...

• Life Sciences
• Sponsorship & Speaking Engagement

• October 6-7, 2026
• Toronto, ON

25th Annual Market Access Summit

CRA is a proud sponsor of the event for market access, reimbursement, and government policy experts. Ashley Fraser presents on “MFN – Implications in...

• Antitrust & Competition
• Sponsorship & Speaking Engagement

• October 21, 2026
• New York, NY

GCR Live: Antitrust in Life Sciences

CRA is a proud sponsor of the event. Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market”...